South Korea to approve use of AstraZeneca COVID-19 vaccine for all aged 18-plus

  • The AstraZeneca shot, co-developed by Britain's Oxford University.
10 Feb, 2021

SEOUL: South Korea's drug safety ministry on Wednesday said it will approve use of AstraZeneca PLC's COVID-19 vaccine for all people, including those aged 65 and over.

The AstraZeneca shot, co-developed by Britain's Oxford University, is the first vaccine to be granted approval in the country.

Read Comments